$LRCX
LAM RESEARCH CORP

2023 Q4 Form 10-Q Financial Statement

#000070754923000115 Filed on October 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $3.758B $3.482B
YoY Change -28.79% -31.38%
Cost Of Revenue $2.001B $1.827B
YoY Change -31.04% -33.24%
Gross Profit $1.757B $1.655B
YoY Change -26.04% -29.19%
Gross Profit Margin 46.76% 47.52%
Selling, General & Admin $228.8M $207.0M
YoY Change -1.58% 1.23%
% of Gross Profit 13.02% 12.51%
Research & Development $469.7M $422.6M
YoY Change 1.58% -2.48%
% of Gross Profit 26.73% 25.54%
Depreciation & Amortization $90.92M $90.50M
YoY Change 6.45% 19.47%
% of Gross Profit 5.17% 5.47%
Operating Expenses $700.2M $631.7M
YoY Change 0.58% -1.15%
Operating Profit $1.057B $1.023B
YoY Change -37.08% -39.75%
Interest Expense $46.31M $45.33M
YoY Change -0.75% -1.57%
% of Operating Profit 4.38% 4.43%
Other Income/Expense, Net $29.84M $2.601M
YoY Change -205.68% -106.04%
Pretax Income $1.087B $1.026B
YoY Change -34.2% -38.02%
Income Tax $132.8M $138.2M
% Of Pretax Income 12.22% 13.48%
Net Earnings $954.3M $887.4M
YoY Change -35.02% -37.76%
Net Earnings / Revenue 25.39% 25.48%
Basic Earnings Per Share $7.25 $6.69
Diluted Earnings Per Share $7.22 $6.66
COMMON SHARES
Basic Shares Outstanding 131.8M shares 132.5M shares
Diluted Shares Outstanding 132.2M shares 133.2M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.638B $5.157B
YoY Change 22.89% 17.82%
Cash & Equivalents $5.623B $5.126B
Short-Term Investments $14.72M $31.00M
Other Short-Term Assets $279.2M $278.0M
YoY Change 20.94% -9.02%
Inventory $4.430B $4.748B
Prepaid Expenses
Receivables $2.707B $2.811B
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.05B $12.99B
YoY Change -4.77% -4.55%
LONG-TERM ASSETS
Property, Plant & Equipment $2.147B $2.111B
YoY Change 15.26% 22.82%
Goodwill $1.600B $1.600B
YoY Change 0.0% 6.67%
Intangibles $151.1M $157.6M
YoY Change -18.24% 42.79%
Long-Term Investments
YoY Change
Other Assets $1.804B $1.650B
YoY Change -1.37% -6.49%
Total Long-Term Assets $5.729B $5.545B
YoY Change 4.21% 8.54%
TOTAL ASSETS
Total Short-Term Assets $13.05B $12.99B
Total Long-Term Assets $5.729B $5.545B
Total Assets $18.78B $18.54B
YoY Change -2.2% -0.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $499.7M $528.2M
YoY Change -45.65% -53.92%
Accrued Expenses $1.976B $2.120B
YoY Change -4.47% 8.79%
Deferred Revenue $1.793B
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.779M $4.000M
YoY Change -47.7% -43.74%
Total Short-Term Liabilities $4.272B $4.247B
YoY Change -6.04% -15.95%
LONG-TERM LIABILITIES
Long-Term Debt $4.980B $4.980B
YoY Change -0.32% -0.33%
Other Long-Term Liabilities $511.4M $483.0M
YoY Change -62.36% -61.64%
Total Long-Term Liabilities $511.4M $483.0M
YoY Change -91.95% -92.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.272B $4.247B
Total Long-Term Liabilities $511.4M $483.0M
Total Liabilities $10.56B $10.49B
YoY Change -3.12% -7.23%
SHAREHOLDERS EQUITY
Retained Earnings $23.35B $22.66B
YoY Change 11.82% 15.33%
Common Stock $131.0K $132.0K
YoY Change -2.96% -2.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.222B $8.047B
YoY Change
Total Liabilities & Shareholders Equity $18.78B $18.54B
YoY Change -2.2% -0.98%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $954.3M $887.4M
YoY Change -35.02% -37.76%
Depreciation, Depletion And Amortization $90.92M $90.50M
YoY Change 6.45% 19.47%
Cash From Operating Activities $1.454B $951.2M
YoY Change 27.51% -20.04%
INVESTING ACTIVITIES
Capital Expenditures $115.3M $77.00M
YoY Change -170.55% -154.98%
Acquisitions
YoY Change
Other Investing Activities $13.33M $4.966M
YoY Change -112.83% -59.49%
Cash From Investing Activities -$101.9M -$74.68M
YoY Change -61.86% -41.56%
FINANCING ACTIVITIES
Cash Dividend Paid $230.3M
YoY Change 12.02%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -859.9M -$1.326B
YoY Change 29.85% 326.45%
NET CHANGE
Cash From Operating Activities 1.454B $951.2M
Cash From Investing Activities -101.9M -$74.68M
Cash From Financing Activities -859.9M -$1.326B
Net Change In Cash 492.0M -$460.6M
YoY Change 133.46% -161.34%
FREE CASH FLOW
Cash From Operating Activities $1.454B $951.2M
Capital Expenditures $115.3M $77.00M
Free Cash Flow $1.339B $874.2M
YoY Change 2.68% -34.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2023Q3 us-gaap Investments
Investments
30557000 usd
CY2023Q2 us-gaap Investments
Investments
37641000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5255000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5344000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2810953000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2823376000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
4747781000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
4816190000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
278121000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
214149000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
12993562000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
13228412000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2110511000 usd
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1856672000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1626382000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
1622489000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
157618000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
168454000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1650384000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1905616000 usd
CY2023Q3 us-gaap Assets
Assets
18538457000 usd
CY2023Q2 us-gaap Assets
Assets
18781643000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
528163000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
470702000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2120055000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2010637000 usd
CY2023Q3 lrcx Contract With Customer Liabilities Net Current
ContractWithCustomerLiabilitiesNetCurrent
1595098000 usd
CY2023Q2 lrcx Contract With Customer Liabilities Net Current
ContractWithCustomerLiabilitiesNetCurrent
1695221000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3861000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
8358000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4247177000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4184918000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4980460000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5003183000 usd
CY2023Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
780511000 usd
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
882084000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
482979000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
501286000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
10491127000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
10571471000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132072000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132072000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
133297000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
133297000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
132000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
133000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7879031000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7809002000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
162646000 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
161380000 shares
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
22365872000 usd
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
21530353000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-121350000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100706000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22655389000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22032096000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
8047330000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8210172000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18538457000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18781643000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
887398000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1425879000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
90479000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
75751000 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-24238000 usd
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-133616000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
67211000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
71110000 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
150000 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2751000 usd
CY2023Q3 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
69537000 usd
CY2022Q3 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
246785000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
951163000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1189588000 usd
CY2023Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
76992000 usd
CY2022Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
140063000 usd
CY2023Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7275000 usd
CY2022Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
14695000 usd
CY2023Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4966000 usd
CY2022Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2435000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74683000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-127803000 usd
CY2023Q3 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
253109000 usd
CY2022Q3 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
1854000 usd
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
843238000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
109779000 usd
CY2023Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
230332000 usd
CY2022Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
205615000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2818000 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6796000 usd
CY2023Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2151000 usd
CY2022Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-489000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1326012000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-310941000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11031000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-16925000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-460563000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
733919000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5587372000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3773535000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5126809000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4507454000 usd
CY2023Q3 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
37768000 usd
CY2022Q3 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
88000 usd
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
38668000 usd
CY2022Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
79173000 usd
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
265040000 usd
CY2022Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
235980000 usd
CY2023Q3 lrcx Transfer Of Inventory To Property And Equipment Net
TransferOfInventoryToPropertyAndEquipmentNet
18014000 usd
CY2022Q3 lrcx Transfer Of Inventory To Property And Equipment Net
TransferOfInventoryToPropertyAndEquipmentNet
20798000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5126150000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4256499000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
659000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
250955000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5126809000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4507454000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8210172000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2818000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
835520000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
67211000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
887398000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20644000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.00
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
264105000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
8047330000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6278366000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6796000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
109821000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
71110000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1425879000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23783000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.725
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
235980000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7412567000 usd
CY2023Q3 us-gaap Fiscal Period
FiscalPeriod
The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 30, 2024 and includes 53 weeks.
CY2023Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Reclassification: Certain amounts for the June 25, 2023 Condensed Consolidated Balance Sheet and notes to the financial statements have been reclassified to conform to the current period presentation.
CY2023Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q3 lrcx Numberof Operating Geographic Regions
NumberofOperatingGeographicRegions
7 region
CY2023Q3 lrcx Numberof Primary Markets
NumberofPrimaryMarkets
3 primary_market
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3482062000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5074121000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3482062000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5074121000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
561800000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.31
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1837900000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
42035000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1690447000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
67211000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
71110000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
9564000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
11528000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
56564000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
15056000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
45331000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
46052000 usd
CY2023Q3 lrcx Gain Losson Assets Relatedto Deferred Compensation Plan
GainLossonAssetsRelatedtoDeferredCompensationPlan
-2901000 usd
CY2022Q3 lrcx Gain Losson Assets Relatedto Deferred Compensation Plan
GainLossonAssetsRelatedtoDeferredCompensationPlan
-12726000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1269000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6821000 usd
CY2023Q3 lrcx Other Non Operating Income Expense Other Net
OtherNonOperatingIncomeExpenseOtherNet
-7000000 usd
CY2022Q3 lrcx Other Non Operating Income Expense Other Net
OtherNonOperatingIncomeExpenseOtherNet
-6194000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2601000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-43095000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
138232000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
228866000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.135
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.138
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
3384670000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
887398000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1425879000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132584000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136891000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
582000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
317000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133166000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137208000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.69
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
10.42
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.66
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.39
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5126150000 usd
CY2023Q3 us-gaap Investments
Investments
30557000 usd
CY2023Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
115625000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5337056000 usd
CY2023Q2 us-gaap Investments
Investments
37641000 usd
CY2023Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
356985000 usd
CY2023Q3 lrcx Available For Sale And Trading Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleAndTradingSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
5977000 usd
CY2023Q3 lrcx Available For Sale And Trading Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleAndTradingSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
7000 usd
CY2023Q3 lrcx Available For Sale And Trading Securities Continuous Unrealized Loss Position12 Months Or Longer
AvailableForSaleAndTradingSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger
39622000 usd
CY2023Q3 lrcx Available For Sale And Trading Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleAndTradingSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2138000 usd
CY2023Q3 lrcx Available For Sale And Trading Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleAndTradingSecuritiesContinuousUnrealizedLossPositionFairValue
45599000 usd
CY2023Q3 lrcx Available For Sale And Trading Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleAndTradingSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
2145000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3384500000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
0 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3384670000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3384500000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3202468000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3196988000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
300408000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
325611000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1244905000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1293591000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
4747781000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
4816190000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1600000000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
1600000000 usd
CY2023Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
65400000 usd
CY2023Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
65400000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1580203000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1435032000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
145171000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1561001000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1422628000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
138373000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1592650000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1435032000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
157618000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1591082000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1422628000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
168454000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14000000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11600000 usd
CY2023Q3 lrcx Finite Lived Intangible Assets Gross Not Yet Placed In Service
FiniteLivedIntangibleAssetsGrossNotYetPlacedInService
18800000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
32556000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
30544000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
20100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
15360000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
11842000 usd
CY2023Q3 lrcx Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
15928000 usd
CY2023Q3 lrcx Finite Lived Intangible Assets Excluding Assets Not Yetin Service Net
FiniteLivedIntangibleAssetsExcludingAssetsNotYetinServiceNet
126330000 usd
CY2023Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
485419000 usd
CY2023Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
481354000 usd
CY2023Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
240550000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
256781000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
587410000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
460630000 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
265040000 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
231267000 usd
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
3095000 usd
CY2023Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
8014000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
538541000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
572591000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2120055000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2010637000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
286663000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
256258000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
44519000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
88213000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
52236000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
64896000 usd
CY2023Q3 lrcx Standard Product Warranty Accrual Increase Decrease For Warranties Issued
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssued
-50000 usd
CY2022Q3 lrcx Standard Product Warranty Accrual Increase Decrease For Warranties Issued
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssued
-1269000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-13522000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
5208000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
265374000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
283514000 usd
CY2023Q3 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
9000 shares
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5500000 usd
CY2023Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
1650 employee
CY2023Q3 lrcx Restructuring Charges Cost Of Goods Net
RestructuringChargesCostOfGoodsNet
7900000 usd
CY2023Q3 lrcx Restructuring Charges Operating Expense Net
RestructuringChargesOperatingExpenseNet
2000000 usd
CY2022Q3 lrcx Restructuring Charges Cost Of Goods Net
RestructuringChargesCostOfGoodsNet
0 usd
CY2022Q3 lrcx Restructuring Charges Operating Expense Net
RestructuringChargesOperatingExpenseNet
0 usd
CY2023Q3 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
130300000 usd
CY2023Q3 us-gaap Restructuring And Related Cost Expected Cost Remaining1
RestructuringAndRelatedCostExpectedCostRemaining1
7000000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
8235000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
9961000 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
14787000 usd
CY2023Q3 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
70000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
3479000 usd
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000707549-23-000115-index-headers.html Edgar Link pending
0000707549-23-000115-index.html Edgar Link pending
0000707549-23-000115.txt Edgar Link pending
0000707549-23-000115-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lrcx-20230924.htm Edgar Link pending
lrcx-20230924.xsd Edgar Link pending
lrcx_1qx2024xexhibitx311.htm Edgar Link pending
lrcx_1qx2024xexhibitx312.htm Edgar Link pending
lrcx_1qx2024xexhibitx321.htm Edgar Link pending
lrcx-20230924_def.xml Edgar Link unprocessable
lrcx-20230924_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
lrcx-20230924_lab.xml Edgar Link unprocessable
lrcx-20230924_pre.xml Edgar Link unprocessable
lrcx-20230924_htm.xml Edgar Link completed
lrcx_1qx2024xexhibitx322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending